Patient with decompensated hepatitis C virus-related cirrhosis delisted for liver transplantation after successful

Isaac RUIZ, Cyrille FERAY, Jean-Michel PAWLOTSKY, Christophe HEZODE,

Liver Transpl. 01/03/2015;21(3) : 408-409 10.1002/lt.2405 20/01/2015

[Solid pancreatic tumor: should we always take it out?]

J Salceda, Alain LUCIANI, A Laurent, C Tayar,

Acta Gastroenterol Latinoam 01/03/2015;45(1):9 : 99 .

Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy.

C Sarrazin, H Wedemeyer, G Cloherty, DE Cohen, Stephane CHEVALIEZ, C Herman, B Bernstein, Jean-Michel PAWLOTSKY,

J Virol Methods. 01/03/2015;214 : 29-32 10.1016/j.jviromet.2014.11.027 18/12/2014

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.

JM Michot, D Canioni, H Driss, L Alric, P Cacoub, F Suarez, D Sibon, C Thieblemont, J Dupuis, B Terrier, Cyrille FERAY, H Tilly, S Pol, V Leblond, C Settegrana, P Rabiega, Y Barthe, H Hendel-Chavez, F Nguyen-Khac, H Merle-Beral, F Berger, T Molina, F Charlotte, F Carrat, F Davi, O Hermine, C Besson,

Am J Hematol. 01/03/2015;90(3) : 197-203 10.1002/ajh.23889. 24/11/2014

Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection.

GJ Dore, E Lawitz, Christophe HEZODE, SD Shafran, A Ramji, HA Tatum, G Taliani, A Tran, MR Brunetto, S Zaltron, SI Strasser, N Weis, W Ghesquiere, SS Lee, D Larrey, S Pol, H Harley, J George, SK Fung, V De Ledinghen, P Hagens, F McPhee, D Hernandez, D Cohen, E Cooney, S Noviello, EA Hughes,

Gastroenterology 01/02/2015;148(2) : 355-366.e1 10.1053/j.gastro.2014.10.007 13/10/2014

Double inversion recovery MR sequence for the detection of subacute subarachnoid hemorrhage

J Hodel, R Aboukais, B Dutouquet, E Kalsoum, MA Benadjaoud, D Chechin, M Zins, A Rahmouni, Alain LUCIANI, JP Pruvo, JP Lejeune, X Leclerc,

AJNR Am J Neuroradiol. 01/02/2015;36(2) : 251-258 10.3174/ajnr.A4102. 11/09/2014

HCV RNA assay sensitivity impacts the management of patients treated with direct-acting antivirals.

G Cloherty, D Cohen, C Sarrazin, H Wedemeyer, Stephane CHEVALIEZ, C Herman, B Bernstein, Jean-Michel PAWLOTSKY,

Antivir THER. 01/01/2015;20(2) : 177-183 10.3851/IMP2810 18/06/2014

Macrophage autophagy protects against liver fibrosis in mice.

J Lodder, T Denaes, MN Chobert, J Wan, J El-Benna, Jean-Michel PAWLOTSKY, S Lotersztajn, Fatima TEIXEIRA-CLERC,

Autophagy 01/01/2015;11(8) : 1280-1292 10.1080/15548627.2015.1058473.

Telaprevir enhances ribavirin-induced anaemia through renal function impairment

L Cotte, A Barrail-Tran, C Vincent, MA Valantin, I Fournier, K Lacombe, Stephane CHEVALIEZ, JP Aboulker, AM Taburet, JM Molina,

Antivir Ther. 01/01/2015;20(5) : 479-486 10.3851/IMP2929. 06/01/2015

DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4.

G Everson, C Cooper, Christophe HEZODE, ML Shiffman, E Yoshida, T Beltran-Jaramillo, P Andreone, S Bruno, P Ferenci, S Zeuzem, M Brunda, S Le Pogam, I Najera, J Zhou, MT Navarro, A Voulgari, NS Shulman, ES Yetzer,

Linver Int. 01/01/2015;35(1) : 108-119 10.1111/liv.12471. 12/02/2014